JW Therapeutics opens $300m Hong Kong IPO

By Jonathan Breen
22 Oct 2020

JW (Cayman) Therapeutics set its IPO in motion on Thursday, opening the order book for the up to HK$2.3bn ($300m) deal.

The Chinese biotechnology firm kicked off bookbuilding after three days of pre-deal investor education led by the listing sponsors Goldman Sachs and UBS.

It is floating 97.7m shares at HK$20.00 to HK$23.80, eyeing a market capitalisation of HK$7.5bn to HK$8.9bn. There is also a 15% greenshoe, ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial